What is NRX Pharmaceuticals Inc (NRXP) stock price today?

NRX Pharmaceuticals Inc (NRXP) currently trades at $2.98 per share. The stock has a market capitalization of $100.19M and a P/E ratio of —x.

Is NRXP stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, NRX Pharmaceuticals Inc has a Smart Value Score of 21/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is —/9 and Altman Z-Score is —.

What is NRX Pharmaceuticals Inc's revenue and earnings?

NRX Pharmaceuticals Inc has trailing twelve-month (TTM) revenue of $1.23M with profit margins of 0.00%. Earnings per share (EPS) is $-1.34.

NRXP

NRX Pharmaceuticals Inc

NASDAQ: NRXP · HEALTHCARE · BIOTECHNOLOGY

$2.98

+2.41% today

Updated 2026-04-30

Market cap

$100.19M

P/E ratio

—

P/S ratio

81.79x

EPS (TTM)

$-1.34

Dividend yield

—

52W range

$2 – $4

Volume

0.9M

Market cap

$100.19M

P/E ratio

—

P/S ratio

81.79x

EPS (TTM)

$-1.34

Dividend yield

—

52W range

$2 – $4

Volume

0.9M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.3

Growth

5.0

Quality

C+

2.5

Profitability

5.0

Valuation

C+

—/9

Piotroski F-Score

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →204 stocks currently score above 75

Price targets

Analyst target

$38.25

+1183.56%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

0 Strong Buy4 Buy0 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths

Insufficient data

Risks

- Thin margins at 0.00%

- Negative free cash flow $-3.71M

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$0.00	$0.00	$0.00	$1.23M	$1.23M
Net income	$-39.75M	$-30.15M	$-25.13M	$-28.62M	$360000.00
EPS	—	—	—	—	$-1.34
Free cash flow	$-39.77M	$-21.66M	$-10.64M	$-14.11M	$-3.71M
Profit margin	—	—	—	-2,336.49%	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
NRXP	$100.19M	21	4.3	2.5	5.0	5.0	—	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$336.47B	54	5.3	5.5	7.3	4.8	+42.09%	Buy
AZN	$287.11B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

NRX Pharmaceuticals Inc trades at $2.98. Our Smart Value Score of 21/100 indicates the stock is weak. TTM revenue stands at $1.23M.

Frequently asked questions

What is NRX Pharmaceuticals Inc's stock price?

NRX Pharmaceuticals Inc (NRXP) trades at $2.98.

Is NRX Pharmaceuticals Inc overvalued?

Smart Value Score 21/100 (Grade F, Strong Sell).

What is the price target of NRX Pharmaceuticals Inc (NRXP)?

The analyst target price is $38.25, representing +1183.6% upside from the current price of $2.98.

What is NRX Pharmaceuticals Inc's revenue?

TTM revenue is $1.23M.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio81.79x

ROE-683.00%

Beta1.83

50D MA$2.14

200D MA$2.50

Shares out0.03B

Float0.02B

Short ratio—

Avg volume0.9M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

NRXP vs LLY →NRXP vs JNJ →NRXP vs ABBV →Stock screener →